Match tier
Likely match
Presence
Current · Arkansas
Last published
2019
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
M
M. Fox
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Assistant Professor
Also affiliated: University of Maryland, Baltimore (2000); National Institutes of Health (1993–1996); University of Maryland Medical System (2000); National Heart, Lung, and Blood Institute (1996)
3 h-index
12 pubs
762 cited
Biomedical Subjects
Biography and Research Information
Metrics
- h-index: 3
- Publications: 12
- Citations: 762
Positions
-
Assistant Professor publications 2004–2019University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Cellular Immune Function Assay (ImmuKnow) Values during Treatment of Chronic Gvhd Status with Combined Immunosuppressive Drug and Extracorporeal Photopheresis Therapy (2019)
-
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma (2006)
-
Low Frequency of Treatment-Related Myelodysplastic Syndromes (t-MDS) after Autotransplants (AT) for Multiple Myeloma (MM), Especially If AT Is Applied Early during Treatment. (2005)
-
Complete Response (CR) with Total Therapy 2 (TT2) for Multiple Myeloma (MM): Low Frequency in Case of Prior MGUS without Adverse Consequences for Survival - Yet Critical for Disease Control in Presumed “De Novo” MM. (2005)
-
High-dose treatment (HDT) and autologous stem cell transplant (ASCT) in Waldenstrom’s macroglobulinemia (WM) patients (pts): A single center experience (2005)
-
Successful mobilization of peripheral blood stem cells (PBSCs) with AMD3100 in patients failing to collect with hematopoietic growth factors (HGF) and/or chemotherapy (2004)
-
NY-ESO-1 Specific Antibodies Are Frequently Detected in Hight-Risk Myeloma. (2004)
-
Successful mobilization of peripheral blood stem cells (PBSCs) with AMD3100 in patients failing to collect with hematopoietic growth factors (HGF) and/or chemotherapy (2004)